The Montreal Heart Institute stands out at the prestigious European Society of Cardiology congress
Home > Press room > The Montreal Heart Institute stands out at the prestigious European Society of Cardiology congress
Copied link!
Share
August 31, 2020
─
During the prestigious virtual congress of the European Society of Cardiology (ESC), researchers from the Montreal Heart Institute presented recent data regarding the impact of colchicine on cardiovascular disease.
These three new analyses from the COLCOT (COLchicine Cardiovascular Outcomes Trial) clinical trial confirm the benefits of colchicine, an inexpensive and already available drug, to prevent cardiovascular events in patients who survived a heart attack, also known as myocardial infarction.
find out more by visiting the Institute’s websitePress Room
September 6, 2024The 24th edition of the Bal des Grands Cœurs raised $1,401,000 for the Montreal Heart Institute Foundation
June 17, 2024A historic $140 million bequest to the benefit of our community
December 6, 2023The Right Honourable Brian Mulroney and Mrs. Mila Mulroney donate $1.5 million to support the foundations of two hospitals and a research institute